Back Pain Doctor
Rheumatoid Arthritis of the Foot & Ankle
Written by Dr Joshua Hatch, Musculoskeletal GP, RACGP Fellow, Diploma in Musculoskeletal Medicine (FSEM UK).
Rheumatoid arthritis is an autoimmune disease in which the immune system attacks the lining of the joints, damaging cartilage and ligaments and softening bone. The feet are involved in the great majority of people at some stage, and the pattern is distinctive: symptoms in both feet, affecting the same joints on each side, rather than the single-joint picture typical of osteoarthritis. Weakened ligaments and softened bone drive the characteristic deformities: a collapsing arch, bunions, claw toes and painful prominences under the ball of the foot.
Assessment covers where the pain actually is, since the joints that look worst on X-ray are not always the ones generating symptoms. Examination looks at the pattern of calluses as a map of abnormal pressure, the shape of the foot, whether the affected joints still move, and tenderness in specific joints. X-rays document alignment; CT or MRI are used selectively where the deformity is severe or a tendon problem is suspected. Where inflammatory arthritis is newly suspected, blood tests and urgent rheumatology referral matter. Early disease-modifying treatment is the single biggest determinant of long-term joint outcomes, and normal blood results do not exclude the diagnosis.
First-line foot care is about reducing load and pressure: lower-impact activity such as swimming or cycling, ice after activity, custom orthoses made of softer material to offload prominent bones, supportive footwear with a more rigid sole, and a lace-up or custom-moulded brace for hindfoot and ankle pain. Corticosteroid injection into an affected joint can help in earlier stages and sometimes clarifies which joint is responsible. Podiatry has an established role here and is accessible through chronic disease management arrangements. Surgery (usually fusion, and sometimes ankle replacement) is considered when cartilage damage is advanced and non-surgical measures have been exhausted. Any skin breakdown or ulceration over a bony prominence, or a hot swollen joint with fever in someone on immunosuppressive medication, needs prompt review.
Common symptoms
- Pain, swelling and stiffness in the same joints of both feet
- Difficulty with ramps, stairs or walking on uneven ground
- A collapsing arch or a change in the shape of the foot
- Bunions, claw toes, and painful calluses under the ball of the foot
Evidence for twelve treatment options in rheumatoid arthritis of the foot & ankle
This is not a fixed ladder or a package of treatments. Every option is assessed independently against this diagnosis, including treatments with limited direct research that may still be reasonable for a clearly defined tissue target. The evidence level, likely benefit, risks, cost and alternatives are weighed at consultation.
Foundation: diagnosis, education and rehabilitation
The part of care with the broadest relevance. For many people it is enough on its own; other options are judged against it, not automatically added after it.
Diagnosis, education and progressive rehabilitation Working out what is driving the pain, explaining what your imaging does and does not mean, and building a graded loading plan you can actually follow. Core care
What it involves
Assessment to identify the likely pain source, an explanation of what the diagnosis means, adjustment of the loads that aggravate it, and a progressive strength and conditioning plan, with weight management where that is clinically relevant.
What the evidence shows
Foot care in rheumatoid arthritis rests on education, exercise and foot orthoses alongside disease-modifying medication. A 2024 multidisciplinary guideline supports self-care education, orthoses for pain, function and quality of life, and therapeutic footwear where needed (Ramos-Petersen, Rheumatol Int 2024), as does a Dutch consensus of 41 recommendations covering shoes, orthoses and exercise therapy (Tenten-Diepenmaat, J Foot Ankle Res 2018). For exercise, a 2026 meta-analysis of 13 studies (548 people) found supervised programs reduced foot pain (standardised mean difference -0.68) and improved walking distance by about 48 metres, though some of the studies were not randomised (Cruz-López, Clin Rheumatol 2026). For orthoses, a randomised trial of 98 people with painful rearfoot deformity found custom rigid orthoses reduced foot pain by 19% and disability by 31% over 30 months against usual care, with minor blisters or tender spots in 30% early on (Woodburn, J Rheumatol 2002), and two double-blind trials against flat insoles found less pain but no difference in disability (Moreira, Scand J Rheumatol 2016; Reina-Bueno, Clin Rehabil 2019). Not every analysis agrees: one meta-analysis of five trials found no significant difference from control (Gijon-Nogueron, Qual Life Res 2018), and custom orthoses have not clearly beaten simpler insoles (Novak, Disabil Rehabil 2009; Rome, Scand J Rheumatol 2016).
Pairing reviewed 2026-11-05.
Where it fits
This does not replace rheumatological treatment, and getting the disease under control is what protects the joints of the foot. Assessment here is aimed at recognising the pattern early, making sure that treatment is in place, and then building foot and lower-limb strength, with orthoses or footwear advice where the foot shape calls for it.
Muscle and symptom-modifying options
Useful only when the examination identifies the tissue they target or when short-term pain control creates a useful rehabilitation window.
Wet needling and trigger point injection (trigger point injection) A fine needle into a tender band of muscle, with a small volume of dilute glucose solution injected through it. Only if relevant
What it involves
The needle is placed into the tender muscle band and a small volume of 5% glucose with a very dilute local anaesthetic (0.02-0.08%) is injected. Often done in the same visit as your assessment, and usable where the tender area sits deeper. Dry needling (the same technique with nothing injected) is not offered here.
What the evidence shows
Trigger-point injection reviews address confirmed myofascial pain and find heterogeneous, generally low-certainty results; they do not establish the technique as treatment for the underlying diagnosis. Condition reviewed: rheumatoid arthritis foot ankle.
Evidence source: Debrosse et al., trigger-point injection systematic review (2022)
Pairing reviewed 2026-08-30.
Where it fits
For rheumatoid arthritis foot ankle, this may be considered only when examination finds a separate tender muscle band reproducing part of the pain. It does not treat the primary pathology and is used to help movement or rehabilitation.
Ultrasound-guided injections Guidance means the needle can be seen reaching the target. What goes into the needle depends on the diagnosis. No foot-specific trial
What it involves
The injection is performed under ultrasound so the needle can be watched into the target structure. What is injected is decided by the diagnosis, and corticosteroid is used sparingly, for the reasons set out below.
What the evidence shows
The randomised evidence for corticosteroid injection in rheumatoid arthritis comes mainly from the knee; at the foot and ankle it is observational. Ankles and the joints at the base of the toes were among 1,373 joints injected with betamethasone in a treat-to-target trial of 160 people with early disease, and every joint region showed good two-year survival without a further flare (Hetland, Ann Rheum Dis 2012). In a comparison that was not randomised, 44 people had triamcinolone injected into 70 inflamed ankles, wrists and elbows: the joints were better at two months and back to where they started at five (Mortada, Clin Rheumatol 2018). A review of the field found few studies of corticosteroid injection in the foot and ankle at all (Pekarek, Foot 2011). Ultrasound matters in the forefoot for a different reason: it finds inflamed joints that examination misses. In a randomised trial of ultrasound-informed care in early rheumatoid arthritis, the ultrasound group had nearly twice as many toe-base joints injected (200 against 104), and injections worked best where Doppler showed active inflammation; guiding the needle with ultrasound was no more successful than injecting by feel (Nordberg, Arthritis Rheumatol 2018).
Pairing reviewed 2026-10-02.
Where it fits
Considered for an ankle, hindfoot or toe-base joint that stays inflamed despite your regular treatment. Coordinated with your rheumatologist and your systemic treatment, not instead of it. A joint that keeps flaring is a reason to review that treatment rather than to keep injecting.
V-ACTOR vibration therapy (vibration therapy) Low-frequency vibration applied over tender muscle. Not a shockwave, despite sharing the machine. Not offered for this
What it involves
A vibration handpiece is moved over the tender muscle and fascia for a few minutes. It runs from the same STORZ MASTERPULS icon console as radial shockwave but is a separate handpiece delivering a different, gentler form of energy. No needles, no anaesthetic, no downtime.
What the evidence shows
Not appropriate over a systemic inflammatory process, healing bone, an area of osteonecrosis or a complete tendon or ligament rupture.
Pairing reviewed 2026-08-30.
Where it fits
Not offered for this.
Energy-based treatment options
Radial pressure wave, focused shockwave and EMTT have different targets and different evidence. They are assessed separately rather than treated as one category.
Radial or focused shockwave? Read the overviewRadial shockwave (radial pressure wave) Broad treatment across tender muscle and fascia, close to the surface. Tested in RA, not in the feet
What it involves
A handpiece is moved over the tender tissue while ballistic pressure pulses are delivered, using a transmitter head chosen for the tissue, including heads shaped for fascia and for the muscle either side of the spine. The pulse is strongest at the skin and weakens with depth, so this is mainly a myofascial treatment, though it can reach deeper in some areas. No anaesthetic, no downtime, usually a course of sessions about a week apart.
What the evidence shows
Searched 27 October 2026 (the rheumatoid searches named on the main rheumatoid arthritis page, plus radial device terms with arthralgia and inflammatory joint disease: 1 record). No study has tested radial shockwave in the rheumatoid foot or ankle. The nearest evidence is an uncontrolled series of 15 people with rheumatoid joint pain on disease-modifying drugs, whose pain on movement fell from 5.7 to 2.2 out of 10 after three months of radial shockwave; the joints treated are not named in the abstract and there was no comparison group (Liu, Pain Pract 2018).
Pairing reviewed 2026-10-27.
Where it fits
Never a substitute for your rheumatologist's treatment. Discussed only for tender muscle, fascia or a separate mechanical problem in the foot once the disease is controlled, alongside footwear, orthoses and the exercise program.
Focused shockwave (ESWT) A true shock wave converging at depth: for tendon, joint, ligament and bone. Tested in RA, not in the feet
What it involves
A focused system generates an acoustic shock wave that converges at a focal point set at a defined depth, concentrating the energy where the target is. This is the form used for tendon, joint, ligament and bone. Typically four to six sessions about a week apart, no anaesthetic and no formal downtime.
What the evidence shows
Searched 27 October 2026 (the rheumatoid searches named on the main rheumatoid arthritis page: 8 records, all read). No study has tested shockwave in the rheumatoid foot or ankle. The nearest evidence is one small randomised trial in rheumatoid wrists and knees, where focused shockwave lowered pain more than diclofenac and methotrexate over 14 days (40 people, 4.9 to 1.2 against 4.8 to 2.6 out of 10; Zhang, Pain Res Manag 2024), a trial that was short, allocated by alternating numbers and used an unusual comparison. Nothing shows that shockwave changes the disease.
Pairing reviewed 2026-10-27.
Where it fits
Never a substitute for your rheumatologist's treatment. Discussed only for a separate, persisting mechanical problem in the foot, such as plantar heel or Achilles pain, once the disease is controlled, alongside footwear, orthoses and the exercise program.
EMTT (magnetotransduction therapy) High-energy magnetic pulses applied over the area. Usually painless, no contact. Only if relevant
What it involves
You sit with the applicator positioned over the area for a short session. It is usually painless and needs no gel or skin contact. It is usually given as a course, commonly alongside shockwave.
What the evidence shows
No evidence in this condition, and the rationale offered for EMTT (an effect on tendon and soft-tissue cell behaviour) does not apply to a systemic, bone or complete structural problem.
Pairing reviewed 2026-08-30.
Where it fits
Not part of the plan here.
Biologic and joint injection options
Each injection is assessed independently for the named diagnosis. Cost, uncertainty, likely benefit, risks and alternatives are part of the decision.
Platelet-rich plasma (PRP) Your own blood, concentrated and injected under ultrasound guidance. Not offered for a rheumatoid joint
What it involves
Blood is taken from your arm, spun to concentrate the platelets, and injected into the target under ultrasound guidance in the same appointment.
What the evidence shows
No study reports the result of a PRP injection on its own at a rheumatoid foot or ankle. The one randomised trial in rheumatoid arthritis compared three monthly PRP injections with a single cortisone injection in 60 people with one or two persistently painful joints, and found the improvement lasted to six months only with PRP (Saif, Curr Rheumatol Rev 2021). A later review says ankles were among the joints treated, but the trial's published summary does not report them separately and gives no figures (Moeda, Cureus 2022). The only study specific to the ankle is of PRP added after an operation. In 138 people followed for five years after keyhole removal of the inflamed lining of the ankle, those who also had three or more PRP injections into the ankle showed less decline in ankle scores and less X-ray change than those who had fewer or none. PRP was not allocated at random, so the groups are not a fair comparison, and the authors say a randomised trial is needed (Zhang, J Orthop Traumatol 2025). A PubMed search in October 2026 pairing platelet-rich plasma with rheumatoid arthritis and the foot, forefoot or ankle returned three records, and the other two are general reviews of foot and ankle injections.
Pairing reviewed 2026-10-12.
Where it fits
Not offered here for a rheumatoid joint in the foot or ankle. Rheumatoid disease in the foot depends on disease-modifying medication, footwear and orthoses, with a cortisone injection for a joint that flares, coordinated with your rheumatologist. A separate, clearly identified tendon or soft-tissue problem in the same foot is assessed on that problem's own evidence.
Prolotherapy (dextrose) A course of dextrose injections into and around the structure and its attachments. No study in a rheumatoid joint
What it involves
Hypertonic dextrose is injected at the tender ligament and tendon attachments, and into the joint where relevant, usually as a series of treatments a few weeks apart.
What the evidence shows
No study has tested prolotherapy in rheumatoid arthritis of the foot or ankle, or in rheumatoid arthritis anywhere. PubMed searches on 17 October 2026 (prolotherapy, dextrose injection, hypertonic dextrose, hyperosmolar dextrose or regenerative injection therapy with rheumatoid arthritis, rheumatoid foot, synovitis or inflammatory arthritis, then randomised-trial and systematic-review passes) returned no trial or series. A review of foot injection techniques discusses cortisone and hyaluronic acid for rheumatoid feet and does not report prolotherapy there (Urits, Pain Ther 2020).
Pairing reviewed 2026-10-17.
Where it fits
Not a treatment for the inflammatory disease, which is controlled by your rheumatologist, with footwear, orthoses and podiatry for the foot. Prolotherapy is considered only for a separate ligament or tendon problem in someone whose disease is well controlled, assessed on its own evidence.
Viscosupplementation (hyaluronic acid) A gel-like injection into an arthritic joint. Widely used, and genuinely contested. One small pilot trial
What it involves
One or a short series of hyaluronic acid injections into the joint under ultrasound guidance.
What the evidence shows
This is the one rheumatoid site with a randomised trial of hyaluronic acid. Forty-four people with 75 painful rheumatoid ankle and foot joints were randomised to ultrasound-guided low-molecular-weight hyaluronic acid or lignocaine at fortnightly intervals. At four weeks the hyaluronic acid group had better pain scores (p = 0.009) and better foot function index scores on two subscales, and Doppler signal fell in 54% of injected joints against 20% of controls, though hyaluronic acid was no better than lignocaine at reducing that signal, and synovial thickening did not change in either group (Wang, Mod Rheumatol 2017). The gains were short-term and the trial was an explicitly labelled pilot. The wider overview behind the EULAR intra-articular recommendations still finds the inflammatory-arthritis data too limited to draw a firm conclusion (Rodriguez-García, RMD Open 2021).
Pairing reviewed 2026-09-12.
Where it fits
Worth discussing for a single ankle or forefoot joint that stays painful despite good rheumatoid disease control. Expect a few weeks to a few months of benefit rather than a lasting change, and keep it alongside rheumatological treatment rather than instead of it.
Nerve-targeted options
Relevant when examination identifies a superficial neuropathic pattern or a compressed peripheral nerve, not simply because pain is present.
Lyftogt perineural therapy (perineural injection therapy) A series of small dilute dextrose injections just under the skin, over tender superficial nerves. Only if relevant
What it involves
Small injections of low-concentration dextrose, usually 5%, placed just beneath the skin along tender superficial nerves. Given as a series of short sessions.
What the evidence shows
Perineural dextrose evidence is concentrated in diagnosed peripheral compression neuropathies, particularly the upper limb; no direct evidence was identified for this diagnosis itself. Condition reviewed: rheumatoid arthritis foot ankle.
Evidence source: Perineural dextrose for upper-limb entrapment neuropathy review (2025)
Pairing reviewed 2026-08-30.
Where it fits
For rheumatoid arthritis foot ankle, perineural treatment may be considered only if a separate superficial neuropathic pain pattern is found on examination. It is not treatment of the primary diagnosis.
Ultrasound-guided nerve hydrodissection Fluid placed around a nerve to free it from the surrounding tissue. Only if relevant
What it involves
Under ultrasound, fluid is placed in the plane around the nerve to separate it from the tissue that is tethering or compressing it.
What the evidence shows
Hydrodissection evidence is concentrated in ultrasound-confirmed peripheral nerve entrapment, especially carpal tunnel syndrome; no direct evidence was identified for this diagnosis itself. Condition reviewed: rheumatoid arthritis foot ankle.
Evidence source: Buntragulpoontawee et al., hydrodissection injectate review (2021)
Pairing reviewed 2026-08-30.
Where it fits
For rheumatoid arthritis foot ankle, hydrodissection may be considered only if ultrasound and examination identify a separate compressed or tethered peripheral nerve. It is not treatment of the primary diagnosis.
This is general information only and suitability is assessed individually. Treatments with limited or condition-dependent evidence may still be discussed, but only with clear explanation of the uncertainty, the expected benefit, risks, cost and alternatives. Red flags, progressive neurological symptoms or suspected serious pathology require a different pathway.
Every treatment above is described in full on the non-surgical treatments page, including what each one is used for and what the evidence supports. Ratings apply to the named diagnosis; an adjacent muscle, tendon, joint or nerve problem is assessed as a separate target. The method behind the ratings, and the treatments not offered, are set out on the evidence page.
Corticosteroid injection is reviewed separately for each diagnosis.
Cortisone reliably reduces pain in the short term, and that can be genuinely useful when pain is stopping you sleeping or moving enough to rehabilitate. Beyond that window the picture changes. A systematic review of 41 randomised trials and 2,672 participants found that corticosteroid injection reduced pain in the short term but that the effect reversed at intermediate and long term; in pooled analysis for lateral epicondylalgia the short-term effect was large (SMD 1.44, 95% CI 1.17 to 1.71) while no intervention was favoured at 26 weeks (-0.40, -0.67 to -0.14) and at 52 weeks (-0.31, -0.61 to -0.01) (Coombes, Lancet 2010). In a randomised trial in lateral epicondylalgia, 83 per cent of the corticosteroid group had completely recovered or much improved at one year against 96 per cent given a placebo injection, and recurrence ran at 54 per cent against 12 per cent; adding physiotherapy made no significant difference at one year (Coombes, JAMA 2013). In joints, repeated corticosteroid injections have been associated with cartilage loss. It does not repair anything.
So treatment plans are not built around it. Where an injection is the right call, the specific diagnosis and target are reviewed, what is being injected and why is discussed, the number is kept low, and it is paired with the loading work that changes the longer-term course.
When it might still be considered
- Pain severe enough to block rehabilitation
- A clear inflammatory or bursal target on imaging
- A specific short-term goal: a trip, a procedure, a return to work
- Diagnostic use, where the response shows where the pain is coming from
When a cortisone injection is worth doing, and when it is not
Other foot, ankle & lower leg conditions
Pain in the same area can come from more than one source, and the label matters less than what the examination and history point to. These are the other guides for this region.
Frequently asked questions
Why do my feet hurt before anything else?
Will orthoses or better shoes stop the disease?
What kind of orthotic is best?
Ready for a clearer plan for your back or musculoskeletal pain?
Book an assessment with Dr Joshua Hatch.
Your assessment focuses on understanding the likely source of your pain and the most appropriate non-surgical options for your diagnosis, with the aim of reducing pain and improving function.
You must have your own regular GP before booking. This service works alongside your GP for focused care. Booking requirements.
Book an appointment